In the last trading session, 4.42 million shares of the Genprex Inc (NASDAQ:GNPX) were traded, and its beta was -0.46. Most recently the company’s share price was $0.31, and it changed around $0.02 or 6.90% from the last close, which brings the market valuation of the company to $7.49M. GNPX currently trades at a discount to its 52-week high of $4.09, offering almost -1219.35% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 29.03% since then.
Genprex Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended GNPX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Genprex Inc (NASDAQ:GNPX) trade information
Instantly GNPX has showed a green trend with a performance of 6.90% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3606 on recent trading dayincreased the stock’s daily price by 14.03%. The company’s shares are currently down -63.60% year-to-date, but still up 5.80% over the last five days. On the other hand, Genprex Inc (NASDAQ:GNPX) is -28.17% down in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 27.47%.
GNPX Dividends
Genprex Inc’s next quarterly earnings report is expected to be released on 2025-Mar-30.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 50.69 shares worth $15714.0, making up 0.21% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 14.97 shares worth around $4642.0, which represents about 0.06% of the total shares outstanding.
